Providing policy solutions that allow all patients timely access to innovative therapies can have a better impact on health-rerelated outcomes and quality of life. Read the joint statement on behalf of the MEP Heart Group and the Challenge Cancer Intergroup calling on EU decision making authorities to act if the EU is to achieve the health targets set.